Heyholder
‹ Activism Filings

METABIOMED.CO.,LTD Q3 revenue KRW 24.7 billion, operating profit KRW 2.0 billion, net loss KRW 1.4 billion

METABIOMED.CO.,LTD· Periodic Report

AI summary · Not investment advice

Metabiomed sold KRW 24.7 billion in Q3 and earned KRW 2.0 billion from its main business, down 60.9% from a year earlier and down 68.3% from the previous quarter.

Operating profit · 3 months

KRW 2.0 billion

Key facts

Revenue (3 months)
KRW 24.7 billion
Net income (3 months)
KRW -1.4 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 23.5 billion
Revenue (year to date)
KRW 76.1 billion
Operating profit (prior-year 3 months)
KRW 5.1 billion
Operating profit (year to date)
KRW 13.1 billion
Net income (prior-year 3 months)
KRW 4.5 billion
Net income (year to date)
KRW 9.2 billion

Commentary

AI commentary · Not investment advice

What happened

Metabiomed reported its consolidated results for the 3rd quarter of 2026. Sales for the 3 months were KRW 24.66 billion. That is 4.8% above the same 3 months a year earlier (KRW 23.53 billion) and 8.6% below the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was KRW 1.99 billion. That is 60.9% below the same period a year earlier (KRW 5.08 billion). It is also 68.3% below the previous quarter.

What changes for shareholders

Net income (final profit after taxes and all other items) for the 3 months was a loss of KRW 1.45 billion. A year earlier it was a profit of KRW 4.46 billion, so it turned to a loss. The previous quarter was also a profit.

For the year to date (Jan 1 to Sep 30), sales were KRW 76.07 billion. Operating profit was KRW 13.11 billion. Net income was KRW 9.25 billion.

Comments

No comments yet

Comments from shareholders will appear here.